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The 1955 Salk Polio Vaccine and 
the 1957-61 Niles Leukemia Cluster: 
A Flawed Investigation by 
the U.S. Public Health Service 
by 
Herbert Ratner, M.D. 
Shortly before his death in December, 1997, the author asked that this 
article be published. A Visiting Professor of New York Medical College, 
Department of Community and Preventive Medicine, Valhalla, New York, 
he was also Director of Public Health, Oak Park, Illinois, from 1949 to 
1974 and editor of Child & Family from 1967 to 1997. He was a co-author 
of the December, 1999 article by Michele Carbone in Cancer Research, 
"Unique Strains of SV40 in Commercial Poliovaccines from 1955 Not 
Readily Identifiable with Current Testing for SV40 Infection." 
Abstract 
A 1963 U.S. Public Health Service study of the 1957-1961 leukemia cluster 
of eight children in Niles, IL, gave cursory attention to the possible role of 
the Salk polio vaccine in the etiology of the leukemia. Entitled "Leukemia 
among Children in a Suburban Community," and published in the 
American Journal of Medicine , 34:796-812 June, 1963, the study was 
reprinted as a "Classic in Oncology" in CA - A Cancer Journal for 
Clinicians, 40, 1:27-50 Jan.-Feb., 1990. Focusing on the physical 
environment of the school and church community to which six of the 
children belonged, the study either overlooked or ignored the presence of 
live polio virus in the first two inoculations received by first and second 
graders in Chicago and its suburbs in the spring of 1955. Had the 
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investigators considered the 1955 vaccine as a vector of the disease, their 
conclusions might have been other than to say the etiology of the leukemia 
cluster could not be determined. 
Introduction 
Niles, a small suburb of Chicago, illinois, is famous in epidemiologic 
cancer literature for its cluster of eight cases of leukemia which developed 
in children from 1957 to 1961. Six of these cases attended the town's 
Roman Catholic parochial elementary school. One case, a pre-school child, 
had two older siblings who attended the same school. The eighth case 
attended a neighboring public elementary school and was a close friend and 
contact of one of the six parochial school cases; both were in the 4th grade 
at the time. The leukemia cases were diagnosed between the autumn of 
1957 and the summer of 1960. During the 1960-61 school year the 
parochial school in Niles had 2,723 students and the incidence of childhood 
leukemia in the community was 21.3 cases per 100,000 population. This 
contrasted with a rate of 4.6 cases of leukemia per 100,000 children in the 
rest of Cook County including Chicago, but excluding Niles. 
That something unusual was happening in this small community with 
a child population of 7,076 was first noted by a local woman returning from 
her fourth funeral of a leukemia child in the first three months of 1961. As 
she subsequently informed the author of this article, her observation led her 
to inquire of the Chicago American Cancer Society whether there was a 
"cancer epidemic or something in their area." At the request of the Society, 
she gathered the data on leukemia cases associated with the local parochial 
school. This information was relayed by the Cancer Society to the Centers 
for Disease Control and Prevention in Atlanta (then known as the 
Communicable Disease Center) which assigned a medical officer to study 
the outbreak. 
The investigator was one of a cadre of recently graduated medical 
students who were repaying the federal government for subsidizing part of 
their medical education. He had been recruited by the new Polio 
Surveillance Unit which had been established following the Cutter Salk-
vaccine polio outbreak that occurred shortly after the introduction of the 
Salk vaccine in April, 1955. Given the title "Epidemic Intelligence Service 
Expert," he and the other members of this unit served under Alexander 
Langmuir, M.D., of the United States Public Health Service (USPHS) who 
was chief of the Poliomyelitis Surveillance Unit. The study published as a 
result of this investigation was co-authored by the Director of the Argonne 
Cancer Research Hospital of the University of Chicago who was 
specialized in Internal Medicine and radiology and who worked on the 
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project on a part-time basis. The Illinois Cook County Health Department 
was a cooperating agency. 
Upon its completion, the authors' detailed investigation was 
submitted to the American Journal of Medicine on July 27, 1962 under the 
title "Leukemia among Children in a Suburban Community" and was 
published in June, 1963 (34: 796-812).' In 1990 the study was reprinted as 
a "Classic in Oncology" in CA -A Cancer lournalfor Clinicians.2 In his 
introduction to the reprinted article, Curtis Metlin, Ph.D. , Chief of 
Epidemiologic Research and Director of Cancer Control at Roswell Park 
Memorial Institute in Buffalo, NY, wrote that "[t]he expert and thorough 
approach of the investigators marks this report as a model of 
epidemiological analysis and a classic in oncology."3 He emphasized that 
"rather than focusing on a single theory, they evaluated a range of etiologic 
factors."4 He added that "to have so thoroughly searched and failed to find 
the common exposure that would account for the cancer cluster may have 
provided equally important information on the lack of communicability of 
childhood leukemia."s 
Analysis 
The authors judged from the beginning that: "[t]he cluster of eight 
cases of leukemia among children in Niles cannot reasonably be attributed 
to the effects of a random distribution. These cases constituted a clearly 
defined micro-epidemic that occurred within a particular community and 
affected a particular segment of that community 's population. Although 
obscure in etiology, this micro-epidemic presents several distinct 
epidemiologic features."6 
In their discussion of epidemiologic features the authors made clear 
that "[a] conspicuous feature of the eight cases was the absence of direct 
personal contact among the children or their families."7 As a result of their 
inability to find any signs of an infectious process, the authors shifted their 
attention to the school building itself and conducted a thorough study of the 
surrounding physical environment. None of their findings , however, cast 
any light on the etiology of the micro-epidemic. 
Though needed to cover all etiologic possibilities, the investigators' 
intense focus on the locus of the disease sidetracked any further search for 
an infectious process in the children themselves. But before having 
abandoned their search for an infectious process, the investigators did take 
a careful immunization history of each child leukemia case. These histories 
showed that each was fully immunized against diphtheria, pertussis, and 
tetanus (OPT), as well as against small pox and that each child had 
received "at least three polio vaccine inoculations before the onset of 
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illness."g It was found that the children's immunizations did not differ 
from those received by other children in the parochial school and in the 
surrounding community. 
The investigators seemed to recognize, however, that as a newer 
vaccine, the Salk vaccine fell into a different category than the traditional 
long-established childhood vaccines, viz., DPT and small pox. This was 
clearly manifest when they singled out the polio vaccine for comment 
observing that "the interval between the most recent Salk dose and the 
leukemia onset varied from two to eighteen months."9 
This variation in onset interval apparently led the investigators to rule 
out the possibility that the Salk vaccine was the vector of the infectious 
agent. And this was as far as they pursued such a possibility as they had 
chosen the short incubation period of the common contagious diseases of 
childhood as the incubation norm for leukemia. If they had instead taken as 
their model a disease such as tuberculosis in which the lapse of time 
between the initial infection and the manifestation of the disease is much 
longer - many months or years - they might have correlated these 
leukemia cases with the fust inoculation instead of with the third and most 
recent inoculation. 
Had they done so, they would have found that six of the eight 
leukemia cases had received their first Salk vaccine inoculation not in Niles 
but in other sections of Chicago and Cook County and that for this first 
inoculation each child would have received the same vaccine, viz. , the free 
1955 Salk Polio vaccine provided to United States school children by the 
National Foundation for Infantile Paralysis (NFIP). In Cook County the 
vaccine used was from one manufacturer and the first inoculation was 
given shortly after the April 12 internationalized television announcement 
that the Salk vaccine had been approved for use. One should recall that on 
May 7, 1955, the USPHS had to suspend its vaccination program 
temporarily in order to re-examine the safety of the Salk vaccine. This re-
examination was called for after the manufacturer experienced difficulties 
in carrying out the recipe devised by Jonas Salk for the polio-virus 
inactivation process. The vaccination program was not fully resumed until 
May 24, 1955. However, on May 26, 1955, the manufacturer of the 
vaccine used in Cook County stopped manufacture after having detected 
live polio virus in the vaccine. 
All the Niles leukemia cases thus would have received their first 
inoculations between April 12, 1955 and May 26, 1955. Therefore it may 
be seen that the interval between polio inoculation and the onset of 
leukemia in the Niles children did not vary between child and child so 
much as the investigators had supposed. Instead of a putative incubation 
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period which varied between 2 and 18 months, one finds a putative 
incubation period which varies between roughly 2 and 5 years. 
The newly-licensed Salk vaccine had been used for less than two 
years before the first cases of leukemia developed among the Niles school 
children. Let us remember that within three weeks of the Salk vaccine's 
first use both major and minor epidemics of polio had occurred. The major 
epidemics occurred in California, Idaho, and Utah and were immediately 
recognized as such by both public health physicians and the laity. On the 
other hand, the pre-seasonal micro-epidemics (an increased rise and fall in 
polio cases), which developed in about ten states were never publicized 
either by the NFIP or the USPHS. These micro-epidemics were, however, 
noted in the Bulletin of the American Association of Public Health 
Physicians and, there, were denoted as the "Salk Vaccine Post Inoculation 
Phenomenon."lo This phenomenon was independently confirmed in a 1956 
report by the President of the Health Ministry of West Germany where 
similar micro-epidemics of polio after vaccination programs had been 
observed. I I. 12, 13 
Conclusion 
In summary, the three essential points that the authors of the 1962 
Niles study either overlooked or ignored were: 1) the turbulent history of 
the Salk vaccine following its introduction, 2) that in every community in 
the Chicago area except one, every first and second grader, with rare 
exception, received two inoculations of the Salk vaccine in the spring of 
1955, and 3) that the manufacture of Salk vaccine allotted to Illinois was 
discontinued by its manufacturer on May 26, 1955 after the discovery of 
live polio virus in the vaccine. 14 
Overlooked or ignored also was the manner in which the Salk vaccine 
had been licensed on April 12, 1955, the same day it was announced in a 
highly publicized program out of Ann Arbor that the vaccine was "safe, 
effective and potent." These words were taken from the Francis report, 
which was a summary of the 1954 nationwide field trial and which had 
been released as a press communique. IS 
On that day of the licensing of the Salk vaccine, April 12, 1955, the 
full report of the field trial had not, however, yet been made available to the 
USPHS licensing board for review. 16 Thus the USPHS licensing board 
approved the vaccine without having read the full report on which its 
decision was to have been based. If all or even some of this available 
information had been taken into account by the authors of the USPHS Niles 
study, the conclusions of the study regarding the possible role of the Salk 
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polio vaccine in the Niles leukemia cluster might have been other than to 
say that the etiology of the leukemia could not be determined. 
Epilogue: In 1963, when the article "Leukemia among Children in a 
Suburban Community" was published in the American Journal of 
Medicine, the top officials of the USPHS had already been aware for three 
years that a simian virus (eventually named SV40) had been detected in the 
Salk vaccine by government researcher Bernice Eddy, who found that this 
virus caused tumors in hamsters. l7• 18 But not until May, 1961 did the 
USPHS privately order vaccine manufacturers to remove SV 40 from all 
new vaccine. 19 Meanwhile the USPHS continued to allow existing vaccine 
contaminated by simian-virus to be used Up.20 Thus, SV40-contaminated 
vaccine was used till 1963. No reference to the SV40 contamination 
appears in the 1963 AJM article on the Niles cluster. It is unknown whether 
the head officers of the USPHS passed on their knowledge of the presence 
of the SV 40 contaminant to the authors of the 1963 article. 
- H.M. Dietz 
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